Mendus AB: Mendus secures manufacturing partner for establishing potential pivotal trial-stage and commercial production of DCP-001

TECH TRANSFER ALIGNS WITH CLINICAL DEVELOPMENT STRATEGY FOR DCP-001 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced an agreement to... | October 18, 2022

Related Keywords

Mario Brkulj ,Erik Manting ,Leopold Bertea ,Corey Davis ,Lifesci Advisors ,European Society Of Gynecological Oncology ,Valency Communications ,Minaris Regenerative Medicine Gmbh ,Acute Myeloid Leukemia ,Chief Technology Officer ,European Society ,Gynecological Oncology ,Sci Advisors ,Mendus Ab Publ Stock Exchange ,News ,Information ,Press Release ,Tech ,Transfer ,Aaligns ,Ith ,Linical ,Development ,Strategy ,Or ,Mendus ,Tb ,Iopharmaceutical ,Company ,Ocused ,N ,Mmunotherapies ,Ddressing ,Humor ,Oday ,Nnounced ,Greement Immu Se0005003654 ,